BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31070816)

  • 1. Prolonged overall survival following metastasectomy in stage IV melanoma.
    Elias ML; Behbahani S; Maddukuri S; John AM; Schwartz RA; Lambert WC
    J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1719-1725. PubMed ID: 31070816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I).
    Howard JH; Thompson JF; Mozzillo N; Nieweg OE; Hoekstra HJ; Roses DF; Sondak VK; Reintgen DS; Kashani-Sabet M; Karakousis CP; Coventry BJ; Kraybill WG; Smithers BM; Elashoff R; Stern SL; Cochran AJ; Faries MB; Morton DL
    Ann Surg Oncol; 2012 Aug; 19(8):2547-55. PubMed ID: 22648554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does metastasectomy improve survival in patients with Stage IV melanoma? A cancer registry analysis of outcomes.
    Wasif N; Bagaria SP; Ray P; Morton DL
    J Surg Oncol; 2011 Aug; 104(2):111-5. PubMed ID: 21381040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Effective Systemic Therapy on Metastasectomy in Stage IV Melanoma: A Matched-Pair Analysis.
    Nelson DW; Fischer TD; Graff-Baker AN; Dehal A; Stern S; Bilchik AJ; Faries MB
    Ann Surg Oncol; 2019 Dec; 26(13):4610-4618. PubMed ID: 31183639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage-IV melanoma and pulmonary metastases: factors predictive of survival.
    Neuman HB; Patel A; Hanlon C; Wolchok JD; Houghton AN; Coit DG
    Ann Surg Oncol; 2007 Oct; 14(10):2847-53. PubMed ID: 17680317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastasectomy for recurrent stage IV melanoma.
    Ollila DW; Hsueh EC; Stern SL; Morton DL
    J Surg Oncol; 1999 Aug; 71(4):209-13. PubMed ID: 10440757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanoma.
    Bedikian AY; Wei C; Detry M; Kim KB; Papadopoulos NE; Hwu WJ; Homsi J; Davies M; McIntyre S; Hwu P
    Am J Clin Oncol; 2011 Dec; 34(6):603-10. PubMed ID: 21150567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved survival for stage IV melanoma from an unknown primary site.
    Lee CC; Faries MB; Wanek LA; Morton DL
    J Clin Oncol; 2009 Jul; 27(21):3489-95. PubMed ID: 19451446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
    Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete metastasectomy in patients with stage IV metastatic melanoma.
    Ollila DW
    Lancet Oncol; 2006 Nov; 7(11):919-24. PubMed ID: 17081917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical metastasectomy in AJCC stage IV M1c melanoma patients with gastrointestinal and liver metastases.
    Chua TC; Saxena A; Morris DL
    Ann Acad Med Singap; 2010 Aug; 39(8):634-9. PubMed ID: 20838706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of metastasectomy in stageĀ IV cutaneous melanoma.
    Wollina U; Brzezinski P
    Wien Med Wochenschr; 2019 Oct; 169(13-14):331-338. PubMed ID: 29511905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastasectomy for melanoma is associated with improved overall survival in responders to targeted molecular or immunotherapy.
    Medina BD; Choi BH; Rodogiannis KG; Moran U; Shapiro RL; Pavlick A; Osman I; Berman RS; Lee AY
    J Surg Oncol; 2020 Sep; 122(3):555-561. PubMed ID: 32441371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil to lymphocyte ratio is an independent predictor of outcome for patients undergoing definitive resection for stage IV melanoma.
    Kanatsios S; Melanoma Project M; Li Wai Suen CSN; Cebon JS; Gyorki DE
    J Surg Oncol; 2018 Nov; 118(6):915-921. PubMed ID: 30196539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Tumor Thickness is a Prognostic Factor in Stage IV Melanoma: A Retrospective Study of Primary Tumor Characteristics.
    Luen S; Wong SW; Mar V; Kelly JW; McLean C; McArthur GA; Haydon A
    Am J Clin Oncol; 2018 Jan; 41(1):90-94. PubMed ID: 26325493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastasectomy for stage IV melanoma.
    Deutsch GB; Kirchoff DD; Faries MB
    Surg Oncol Clin N Am; 2015 Apr; 24(2):279-98. PubMed ID: 25769712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overall survival in patients with metastatic melanoma.
    Song X; Zhao Z; Barber B; Farr AM; Ivanov B; Novich M
    Curr Med Res Opin; 2015 May; 31(5):987-91. PubMed ID: 25708472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases.
    Faries MB; Mozzillo N; Kashani-Sabet M; Thompson JF; Kelley MC; DeConti RC; Lee JE; Huth JF; Wagner J; Dalgleish A; Pertschuk D; Nardo C; Stern S; Elashoff R; Gammon G; Morton DL;
    Ann Surg Oncol; 2017 Dec; 24(13):3991-4000. PubMed ID: 29019177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma.
    Petersen RP; Hanish SI; Haney JC; Miller CC; Burfeind WR; Tyler DS; Seigler HF; Wolfe W; D'Amico TA; Harpole DH
    J Thorac Cardiovasc Surg; 2007 Jan; 133(1):104-10. PubMed ID: 17198792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of effective systemic therapies on surgery for stage IV melanoma.
    Smith MJF; Smith HG; Joshi K; Gore M; Strauss DC; Hayes AJ; Larkin J
    Eur J Cancer; 2018 Nov; 103():24-31. PubMed ID: 30196107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.